Cargando…
Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage‐colony stimulating factor and interleukin‐2 surface modified MB49 bladder cancer stem cells vaccine
In previous studies, it has been shown that the granulocyte macrophage‐colony stimulating factor (GM‐CSF) or interleukin‐2 (IL‐2) surface modified MB49 bladder cancer stem cells (MCSCs) vaccine could induce a specific antitumor immunity and against bladder cancer in mice model respectively. However,...
Autores principales: | Wang, Chun‐yan, Hua, Rui, Liu, Li, Zhan, Xiaomin, Chen, Simei, Quan, Song, Chu, Qing‐jun, Zhu, Yong‐tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345636/ https://www.ncbi.nlm.nih.gov/pubmed/28205361 http://dx.doi.org/10.1002/cam4.1023 |
Ejemplares similares
-
Prognostic significance of bladder neck involvement in non‐muscle‐invasive bladder cancer: A SEER database analysis with 19,919 patients
por: Zhan, Xiangpeng, et al.
Publicado: (2021) -
Hope and challenge: Precision medicine in bladder cancer
por: Su, Hongwei, et al.
Publicado: (2019) -
Fruits, vegetables, and bladder cancer risk: a systematic review and meta-analysis
por: Vieira, Ana R, et al.
Publicado: (2015) -
Bladder cancer and occupational exposure to diesel and gasoline engine emissions among Canadian men
por: Latifovic, Lidija, et al.
Publicado: (2015) -
Risk factors for upper tract urothelial recurrence following local excision of bladder cancer
por: Lin, Ning, et al.
Publicado: (2018)